Release of the mitochondrial enzyme carbamoyl phosphate synthase under septic conditions

Shock

Volumn 23, Issue 6, 2005, Pages 533-538

  Struck, Joachim ^a   Ühlein, Monika ^a   Morgenthaler, Nils G ^a   Fürst, Walter ^b   Höflich, Conny ^c   Bahrami, Soheyl ^b   Bergmann, Andreas ^a   Volk, Hans Dieter ^c   Redl, Heinz ^b  

^a BRAHMS Aktiengesellschaft ^*  (Germany)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CPS 1; Experimental endotoxemia; Mitochondria; Nonhuman primate; Proteome analysis; Sepsis

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; LIPOPOLYSACCHARIDE; MITOCHONDRIAL ENZYME; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CRITICAL ILLNESS; ENDOTOXEMIA; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME RELEASE; FRAGMENTATION REACTION; GRAM POSITIVE BACTERIUM; LIVER; MITOCHONDRION; NONHUMAN; PRIMATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEPSIS; SMALL INTESTINE; UREA CYCLE;

ANIMALS; ARGININE; BILIRUBIN; BLOTTING, WESTERN; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTOXINS; HUMANS; IMMUNOASSAY; INTESTINE, SMALL; KINETICS; LIPOPOLYSACCHARIDES; LIVER; MASS SPECTROMETRY; MITOCHONDRIA; PAPIO; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; SEPSIS; SUBCELLULAR FRACTIONS; SUBMITOCHONDRIAL PARTICLES; TIME FACTORS; UREA;

EID: 18744415701     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000162236.75253.9e     Document Type: Article

References (36)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Carrigan SD, Scott G, Tabrizian M: Toward resolving the challenges of sepsis diagnosis. Clin Chem 50:1301-1314, 2004.
3. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9:517-524, 2003.
4. Dellinger RP, Parrillo JE: Mediator modulation therapy of severe sepsis and septic shock: does it work? Crit Care Med 32:282-286, 2004.
5. Opal SM: Clinical trial design and outcomes in patients with severe sepsis. Shock 20:295-302, 2003.
6. Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:545-548, 2004.
7. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
8. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454, 1999.
9. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ Jr, Faist E, Reinhart K: Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 31:1560-1567, 2003.
10. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, Padgaonkar VA, Ward PA: Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 159:1199-1209, 2001.
11. Cobb JP, Laramie JM, Stormo GD, Morrissey JJ, Shannon WD, Qiu Y, Karl IE, Buchman TG, Hotchkiss RS: Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med 30:2711-2721, 2002.
12. Redl H, Schlag G: Non-human primate models of sepsis. Sepsis 2:243-253, 1998.
13. Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez-Domenech V, Bergmann A, Muller B: Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 35:290-295, 2003.
14. Struck J, Ühlein M, Bergmann A: New markers of sepsis using proteome analysis. Immuno-analyse & Biologic Spécialisée 19:131-137, 2004.
15. Clarke S: A major polypeptide component of rat liver mitochondria: carbamyl phosphate synthetase. J Biol Chem 251:950-961, 1976.
16. Pierson DL, Brien JM: Human carbamyl phosphate synthetase. 1. Stabilization, purification, and partial characterization of the enzyme from human liver. J Biol Chem. 255:7891-7895, 1980.
17. Ryall J, Nguyen M, Bendayan M, Shore GC: Expression of nuclear genes encoding the urea cycle enzymes, carbamoyl-phosphate synthetase I and ornithine carbamoyl transferase, in rat liver and intestinal mucosa. Eur J Biochem 152:287-292, 1985.
18. Klose J: Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. Methods Mol Biol 112:67-85, 1999.
19. Klose J, Kobalz U: Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16:1034-1059, 1995.
20. Morgenthaler NG, Struck J, Thomas B, Bergmann A: Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234-236, 2004.
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874. 1992.
22. Wu G, Morris SM, Jr: Arginine metabolism: nitric oxide and beyond. Biochem J 336:1-17, 1998.
23. Argaman Z, Young VR, Noviski N, Castillo-Rosas L, Lu XM, Zurakowski D, Cooper M, Davison C, Tharakan JF, Ajami A, Castillo L: Arginine and nitric oxide metabolism in critically ill septic pediatric patents. Crit Care Med 31:591-597, 2003.
24. Tabuchi S, Gotoh T, Miyanaka K, Tomita K, Mori M: Regulation of genes for inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock. Biochem Biophys Res Commun 268:221-224, 2000.
25. Lin JM, Fussell KM, Cunningham G, Christman BW: Endotoxemia reduces urea cycle function by an oxidant mediated mechanism prevention by thiol repletion. Crit Care Med 266:A253, 2003.
26. Makowski GS, Ramsby ML: Limited degradation of carbamoyl phosphate synthetase I by calcium-activated protease (calpain): electrophoretic evidence for removal of the C-terminal N-acetylglutamaze regulatory domain. Res Commun Mol Pathol Pharmacol 103:295-310, 1999.
27. Ozaki M, Terada K, Kanazawa M, Fujiyama S, Tomita K, Mori M: Enzyme-linked immunosorbent assay of carbamoylphosphate synthetase 1: plasma enzyme in rat experimental hepatitis and its clearance. Enzyme Protein 48:213-221, 1994.
28. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D: Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis. Am J Physiol 269:G297-G304, 1995.
29. Aranda-Michel J, Sherman KE: Tests of the liver: use and misuse. Gastroenterologist 6:34-43, 1998.
30. Rej R: Aminotransferases in disease. Clin Lab Med 9:667-687, 1989.
31. Hubbard WJ, Bland KI, Chaudry IH: The role of the mitochondrion in trauma and shock. Shock 22:395-402, 2004.
32. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, DE Wolf-Peeters C, Van den Berghe G: Protection of hepatocyte mitochondrial ultrastracture and function by strict blood glucose control with insulin in critically ill patients. Lancet 365:53-59, 2005.
33. Gellerich FN, Trumbeckaite S, Opalka JR, Gellerich JF, Chen Y, Neuhof C, Redl H, Werdan K, Zierz S: Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci Rep 22:99-113, 2002.
34. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR: Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 30:276-284, 2002.
35. Crouser ED, Julian MW, Weinstein DM, Fahy RJ, Bauer JA: Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med 161:1705-1712, 2000.
36. Yang H, Wang H, Tracey KJ: HMG-1 rediscovered as a cytokine. Shock 15:247-253, 2001.